Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 INR | +0.59% |
|
-.--% | -21.15% |
2022 | R J Biotech Limited Auditor Raises 'Going Concern' Doubt | CI |
2022 | R J Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022 | CI |
Sales 2021 | 158M 1.89M 149M | Sales 2022 | 139M 1.66M 131M | Capitalization | 48.95M 586K 46.11M |
---|---|---|---|---|---|
Net income 2021 | -157M -1.88M -148M | Net income 2022 | -91M -1.09M -85.72M | EV / Sales 2021 | 2.97 x |
Net Debt 2021 | 405M 4.84M 381M | Net Debt 2022 | 511M 6.12M 482M | EV / Sales 2022 | 4.03 x |
P/E ratio 2021 |
-0.41
x | P/E ratio 2022 |
-0.53
x | Employees | 110 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 39.68% |
1 day | +0.59% | ||
3 months | +1.48% | ||
6 months | -17.35% | ||
Current year | -21.15% |
![Extreme 3.11](/images/extremecours_fleche.png)
![Extreme 3.11](/images/extremecours_fleche.png)
![Extreme 3.11](/images/extremecours_fleche.png)
![Extreme 3.11](/images/extremecours_fleche.png)
![Extreme 3.11](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 40 | 30/06/20 | |
Compliance Officer | - | 10/01/22 | |
Dnyaneshwar Kale
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 43 | 04/03/21 | |
Chairman | - | 13/06/19 | |
Director/Board Member | - | 04/01/19 |
- Stock Market
- Equities
- RJBIOTECH6 Stock